Unum Group (NYSE:UNM) Releases Quarterly Earnings Results

Unum Group (NYSE:UNM) posted its quarterly earnings data on Tuesday. The financial services provider reported $2.03 earnings per share for the quarter, missing the consensus estimate of $2.14 by ($0.11), Zacks reports. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. Unum Group updated its FY 2025 guidance to 9.120-9.450 EPS.

Unum Group Price Performance

Shares of NYSE:UNM opened at $77.67 on Thursday. Unum Group has a one year low of $46.64 and a one year high of $78.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.28 and a quick ratio of 0.28. The firm has a market capitalization of $14.18 billion, a price-to-earnings ratio of 8.41, a PEG ratio of 1.08 and a beta of 0.80. The company’s fifty day moving average price is $74.24 and its 200-day moving average price is $65.08.

Unum Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be given a dividend of $0.42 per share. The ex-dividend date is Friday, January 24th. This represents a $1.68 annualized dividend and a yield of 2.16%. Unum Group’s payout ratio is presently 18.18%.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNM. Morgan Stanley raised their price target on shares of Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 30th. Jefferies Financial Group raised their target price on Unum Group from $91.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, December 10th. Bank of America upped their price target on Unum Group from $54.00 to $63.00 and gave the company a “neutral” rating in a research report on Thursday, October 10th. UBS Group raised Unum Group to a “hold” rating in a report on Wednesday, October 9th. Finally, Piper Sandler upped their price objective on shares of Unum Group from $82.00 to $87.00 and gave the company an “overweight” rating in a report on Thursday. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.45.

Insider Transactions at Unum Group

In other news, CEO Richard P. Mckenney sold 58,865 shares of the company’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $75.39, for a total value of $4,437,832.35. Following the completion of the transaction, the chief executive officer now directly owns 1,007,003 shares in the company, valued at approximately $75,917,956.17. This represents a 5.52 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total value of $769,200.00. Following the transaction, the executive vice president now directly owns 54,827 shares in the company, valued at approximately $4,217,292.84. This represents a 15.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 98,164 shares of company stock valued at $7,346,040. Insiders own 0.93% of the company’s stock.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.